STEM CELL CARTILAGE REGENERATION MARKET ANALYSIS

Stem Cell Cartilage Regeneration Market, by Stem Cell Type (Hematopoietic Stem Cells (HSCs), Pluripotent Stem Cells (iPSC/ESCs), Mesenchymal Stem Cells (MSCs)), by Treatment (Microfracture, Osteochondral Transplant, Autologous Chondrocyte Implantation, Stem Cell Injections), By End User (Hospitals, Ambulatory Surgical Centers) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Published In : Apr 2023
Code : CMI2448
Pages :154
Formats :
Excel and PDF
Industry : Biotechnology

Market News

Global Stem Cell Cartilage Regeneration Market: Key Developments

Increasing adoption of minimally invasive surgical procedures is expected to drive the growth of the global stem cell cartilage regeneration market. Stem cell therapy for knees, a minimally invasive procedure has the potential to decrease inflammation, halt the progression of arthritic damage, repair joint cartilage, and delay or avoid knee replacement surgery. Injection of progenitor cells, especially mesenchymal stem cells (MSCs) is found to be an effective and better solution for repairing degenerative cartilage compared to the implantation of differentiated cells such as articular cartilage.